Skip to main content
Figure 4 | BMC Pulmonary Medicine

Figure 4

From: No evidence for altered intracellular calcium-handling in airway smooth muscle cells from human subjects with asthma

Figure 4

Assessing the recovery of [Ca2+] i following Ca2+-uncaging in ASM cells derived from asthmatic and non-asthmatic donors. (A) Representative examples of changes in [Ca2+]i on photolysis of the NP-EGTA Ca2+ cage and the subsequent rate of recovery to pre-uncaging levels of [Ca2+]i. Changes in [Ca2+]i are shown for ASM cells in the absence (blue line) or presence (green line) of the SERCA inhibitor, CPA (10 μM). Inset example photographs of Ca2+ uncaging using a confocal microscope before (i), during (ii) and after (iii) the 405 nm laser flash. (B) Mean Ca2+ uncaging recovery rates (K-CPA) without SERCA inhibition in ASM cells from normal (n = 10) and asthma (n = 10) donors. (C) Mean Ca2+ uncaging recovery rates when SERCA is inhibited (K+CPA) in ASM cells from normal (n = 10) and asthma (n = 12) donors. (D) The difference between K-CPA and K+CPA (∆K), which represents primarily trans-plasmalemmal efflux of Ca2+ in ASM cells, is also plotted for each normal (n = 10) and asthmatic (n = 12) donor. Symbol key: filled circles: GINA 1–3; open circles: GINA 4–5 filled squares: non-asthmatic donors. Data are shown as mean (SEM) and analyzed by Student’s t-test.

Back to article page